Market Place
Sourcing Support
Abeona Therapeutics Announces Employee Inducement Grants
01 May 2026 //
GLOBENEWSWIRE
Abeona Pharma Appoints Keith A. Goldan To Board
07 Apr 2026 //
GLOBENEWSWIRE
Abeona Therapeutics Announces Employee Inducement Grants
06 Apr 2026 //
GLOBENEWSWIRE
Abeona Pharma Reveals 2025 Financials And Corporate Progress
17 Mar 2026 //
GLOBENEWSWIRE
Abeona Pharma Sets 2025 Financials Date, Joins 2026 Leerink
03 Mar 2026 //
GLOBENEWSWIRE
Abeona Pharma Grants New Employee Inducements Per Nasdaq Lr
09 Feb 2026 //
GLOBENEWSWIRE
Abeona Therapeutics Grants Inducement Awards Under Nasdaq Rules
31 Dec 2025 //
GLOBENEWSWIRE
Abeona Therapeutics Names Mohamad Tabrizi Chief Business Officer
15 Dec 2025 //
GLOBENEWSWIRE
Abeona Therapeutics Grants Inducements Under Nasdaq Rule
01 Dec 2025 //
GLOBENEWSWIRE
Abeona Therapeutics Reports Q3 2025 Financials & Corporate Update
12 Nov 2025 //
GLOBENEWSWIRE
Abeona Therapeutics Sets Date For Q3 Financial Results
07 Nov 2025 //
GLOBENEWSWIRE
Abeona Pharma Names James A. Gow Senior VP
20 Oct 2025 //
GLOBENEWSWIRE
Abeona Pharma Reveals Employee Grants Per Nasdaq LR 5635(c)(4)
01 Oct 2025 //
GLOBENEWSWIRE
Abeona Announces New Employee Grants Under Nasdaq Rule 5635(c)(4)
02 Sep 2025 //
GLOBENEWSWIRE
Abeona Therapeutics to Present at Investor Conferences
29 Aug 2025 //
GLOBENEWSWIRE
Abeona Therapeutics Reports Q2 2025 Financials and Corporate
14 Aug 2025 //
GLOBENEWSWIRE
Abeona Therapeutics® Issues New Employee Grants per Nasdaq Rule
01 Aug 2025 //
GLOBENEWSWIRE
Abeona Therapeutics® Announces New Employee Inducement Grants
01 Jul 2025 //
GLOBENEWSWIRE
Abeona Therapeutics® joins U.S. Small-cap and Broad-market Russel
30 Jun 2025 //
GLOBENEWSWIRE
Abeona Therapeutics Announces New Employee Inducement Grants
02 Jun 2025 //
GLOBENEWSWIRE
Abeona Therapeutics to Present at Jefferies Healthcare Conference
30 May 2025 //
GLOBENEWSWIRE
Abeona Therapeutics® Announces New Employee Inducement Grants
07 May 2025 //
GLOBENEWSWIRE
Abeona Therapeutics® Announces New Employee Inducement Grants
01 Apr 2025 //
GLOBENEWSWIRE
Abeona Therapeutics® Reports 2024 Financial Results, Pz-cel Update
20 Mar 2025 //
GLOBENEWSWIRE
Abeona Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
03 Mar 2025 //
GLOBENEWSWIRE
Abeona Announces Employee Inducement Grants Under Nasdaq LR 5635©
03 Feb 2025 //
GLOBENEWSWIRE
Abeona Announces Inducement Grants Under Nasdaq LR 5635(c)(4)
31 Dec 2024 //
GLOBENEWSWIRE
Abeona Therapeutics Reports Q3 2024 Results & Updates
14 Nov 2024 //
GLOBENEWSWIRE
Abeona Therapeutics to Participate in November Investor Conferences
04 Nov 2024 //
GLOBENEWSWIRE
Abeona Announces Inducement Grants Under Nasdaq LR 5635(c)(4)
01 Nov 2024 //
GLOBENEWSWIRE
Abeona Announces New Inducement Grants Under Nasdaq LR 5635(c)(4)
01 Oct 2024 //
GLOBENEWSWIRE
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
03 Sep 2024 //
GLOBENEWSWIRE
Abeona Appoints Bernhardt Zeiher And Eric Crombez To Board Of Directors
14 Aug 2024 //
GLOBENEWSWIRE
Abeona Reports Q2 2024 Results, Concludes FDA Meeting On Pz-cel BLA
12 Aug 2024 //
GLOBENEWSWIRE
Abeona Announces New Employee Inducement Grants
01 Aug 2024 //
GLOBENEWSWIRE
Abeona And Beacon To Evaluate AAV204 Capsid For Ophthalmology Use
11 Jul 2024 //
GLOBENEWSWIRE
Abeona Therapeutics to Present at the Stifel Virtual Cell Therapy Forum
08 Jul 2024 //
GLOBENEWSWIRE
Abeona Announces New Employee Inducement Grants Under Nasdaq Rules
03 Jun 2024 //
GLOBENEWSWIRE
Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference
28 May 2024 //
GLOBENEWSWIRE
Abeona Announces New Employee Inducement Grants
07 May 2024 //
GLOBENEWSWIRE
Abeona Prices $75M Common Stock, Pre-Funded Warrants Offering
03 May 2024 //
GLOBENEWSWIRE
Abeona Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Apr 2024 //
GLOBENEWSWIRE
Abeona Therapeutics Reports Full Year 2023 Financial Results
18 Mar 2024 //
GLOBENEWSWIRE
Abeona Announces Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Mar 2024 //
GLOBENEWSWIRE
Abeona Announces Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Feb 2024 //
GLOBENEWSWIRE
Abeona Therapeutics Announces $50 Million Credit Facility
08 Jan 2024 //
GLOBENEWSWIRE
Abeona Announces Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 Dec 2023 //
GLOBENEWSWIRE
Abeona Announces Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Nov 2023 //
GLOBENEWSWIRE
Abeona Appoints Madhav Vasanthavada, Ph.D., M.B.A. as Chief Commercial Officer
12 Sep 2023 //
GLOBENEWSWIRE
Abeona Therapeutics Announces Participation in Upcoming Investor Conferences
07 Sep 2023 //
GLOBENEWSWIRE
Abeona Therapeutics Announces Closing of $25 Million Registered Direct Offering
07 Jul 2023 //
GLOBENEWSWIRE
Abeona Announces $25M Registered Direct Offering Priced Under Nasdaq Rules
03 Jul 2023 //
GLOBENEWSWIRE
Abeona Therapeutics to Present at the Jefferies Healthcare Conference
01 Jun 2023 //
GLOBENEWSWIRE
Abeona Therapeutics Announces Date Change for First Quarter 2023 Portfolio
22 May 2023 //
GLOBENEWSWIRE
Abeona Reports Full Year 2022 Financial Results and Provides Corporate Update
29 Mar 2023 //
GLOBENEWSWIRE
Abeona Therapeutics Announces New Employee Inducement Grants
24 Mar 2023 //
GLOBENEWSWIRE
Abeona Therapeutics Announces Update on AAV Ophthalmology Program
14 Mar 2023 //
GLOBENEWSWIRE
Abeona Therapeutics Reports Third Quarter 2022 Financial Results
14 Nov 2022 //
GLOBENEWSWIRE
Abeona Therapeutics Announces $35 Million Private Placement Financing
03 Nov 2022 //
GLOBENEWSWIRE
Abeona Announces Positive Topline Results with Both Co-Primary Endpoints
03 Nov 2022 //
GLOBENEWSWIRE
